Gilead Sciences Inc articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/03/31 20:48
2015/03/31 20:48
17m
Currently, there is a startling dichotomy for drug manufactures. On the positive side, populations are aging rapidly in developed markets. This will lead to significantly increased demand for drugs...
2015/03/31 20:48
2015/03/31 20:48
Latest videos
2015/03/31 05:08
2015/03/31 05:08
15h
Pharmacy benefits managers help negotiate the prices that customers pay for prescription drugs. They are seen as a key component in the push to contain soaring costs from specialty drugs, complex...
2015/03/30 06:08
2015/03/30 06:08
1d
CEOs at large US companies collectively realised at least $6 billion more in compensation than initially estimated in annual disclosures in the five years after the financial crisis first hit,...
2015/03/27 05:17
2015/03/27 05:17
4d
FOSTER CITY, Californië--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) kondigde vandaag aan dat het Japans Ministerie van Gezondheid, Arbeid en Welzijn (MHLW) Sovaldi® (sofosbuvir) heeft...
2015/03/27 01:17
2015/03/27 01:17
4d
FOSTER CITY, California--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) ha annunciato oggi che il ministero della salute, del lavoro e del welfare giapponese ha approvato Sovaldi® (sofosbuvir),...
2015/03/27 00:17
2015/03/27 00:17
4d
FOSTER CITY, Californie--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq : GILD) a annoncé aujourd'hui que le Ministère de la santé, du travail et de l'aide sociale (MSTA) du Japon avait autorisé le...
2015/03/26 14:17
2015/03/26 14:17
5d
FOSTER CITY, California--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) ha comunicado hoy que el Ministerio de Salud, Trabajo y Bienestar (MHLW) de Japón ha aprobado Sovaldi® (sofosbuvir), un...
2015/03/26 11:56
2015/03/26 11:56
5d
REUTERS: Conatus Pharmaceuticals Inc said its experimental lead drug was more effective than a placebo in a mid-stage study in patients with a form of fatty liver disease. The drug, emricasan, was...
2015/03/26 06:17
2015/03/26 06:17
5d
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Sovaldi® (sofosbuvir), a...
2015/03/25 17:48
2015/03/25 17:48
6d
The pharmaceutical sector plays a vital part in maintaining the health and well-being of the global populace by developing and marketing lifesaving drugs and medical devices. The global industry is...
2015/03/25 14:49
2015/03/25 14:49
6d
Investing in biotech presents positives and negatives. The biggest positives are that it’s relatively recession-proof; smaller companies have the potential to skyrocket on any given day; baby boomers...
2015/03/25 14:43
2015/03/25 14:43
6d
If you measure a giraffe, you get length; an elephant, circumference. If you measure cost, you get price; outcomes, value. You get what you measure. The one-sided reporting and narrowed focus on the...
2015/03/25 08:50
2015/03/25 08:50
6d
Insight - Top U.S. CEOs reaped billions from stock gains in recent years, Reuters analysis shows BOSTON (Reuters) - CEOs at large U.S. companies collectively realized at least $6 billion (4 billion...
2015/03/24 05:03
2015/03/24 05:03
7d
Prescription drugs spending jumped 13 percent last year, the biggest annual increase since 2003, according to the nation's largest pharmacy benefits manager. Earlier this month Express Scripts...
2015/03/23 22:09
2015/03/23 22:09
7d
NEW YORK (MarketWatch) -- U.S. stocks erased modest gains in the last 15 minutes of trading, finishing slightly lower on Monday. Some market watchers attributed recent volatility in stocks to...
2015/03/23 13:56
2015/03/23 13:56
8d
Gilead is, by far, the largest income producer in the Nasdaq Biotech Index and today's warning from the Biotech behemoth which has dragged the stock down 2.8% this morning, is weighing heavily on the...
2015/03/23 12:54
2015/03/23 12:54
8d
NEW YORK (MarketWatch) -- Gilead Sciences Inc.'s stock GILD, +0.84% slumped 2.7% in premarket trade, after the biopharmaceutical company issued a warning letter to doctors regarding its hepatitis C...
2015/03/18 22:38
2015/03/18 22:38
12d
As drugmakers develop new medicines to battle a liver disease epidemic, they have created an urgent need for better diagnostics to select patients for treatment and assess their drugs’...
2015/03/18 20:56
2015/03/18 20:56
13d
REUTERS: Charity Medecins Sans Frontieres has accused U.S. drugmaker Gilead Sciences Inc GILD.O of restricting access to its breakthrough hepatitis C drug Sovaldi in developing countries as it tries...
2015/03/17 16:44
2015/03/17 16:44
14d
Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila) today announced that it launched an oral therapy called 'SoviHep' to treat Hepatitis C that would be marketed by the specialty division of...
2015/03/31 20:48
2015/03/31 20:48
Latest from Twitter